chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL
Symptoms: Tachypnoea
Clinical narrative: This case was received from a health care professional on 11 March 2009. A four-year-old male patient, with a history of milk allergy and ongoing left serous otitis, received the following vaccinations on 05 March 2009: a left thigh intramuscular fifth injection of TRIPEDIA (lot number reported as C2999AA, which corresponds to DAPTACEL); a left thigh intramuscular fourth dose of IPOL (lot number A0474-2); a right thigh subcutaneous second injection of MMR II (Merck, lot number 1571X); and a right thigh subcutaneous second injection of VARIVAX (Merck, lot number 1784X). Within three to five minutes post-vaccination, the patient developed a tight cough and progressive respiratory distress. He became tachypnic and tachycardic, with oxygen saturation 92% and blood pressure 82/42. Treatment included nebulizer treatments, DECADRON, BENADRYL, and supplemental oxygen, and the patient was transported to the hospital. He responded well to treatment, and the event subsequently recovered.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL, DTAP, IPV, MMR, VARCEL
Symptoms: Cough, Oxygen saturation decreased, Respiratory distress, Tachycardia, Tachypnoea
Clinical narrative: This case was received from a health care professional on 11 March 2009. A four-year-old male patient, with a history of milk allergy and ongoing left serous otitis, received the following vaccinations on 05 March 2009: a left thigh intramuscular fifth injection of TRIPEDIA (lot number reported as C2999AA, which corresponds to DAPTACEL); a left thigh intramuscular fourth dose of IPOL (lot number A0474-2); a right thigh subcutaneous second injection of MMR II (Merck, lot number 1571X); and a right thigh subcutaneous second injection of VARIVAX (Merck, lot number 1784X). Within three to five minutes post-vaccination, the patient developed a tight cough and progressive respiratory distress. He became tachypnic and tachycardic, with oxygen saturation 92% and blood pressure 82/42. Treatment included nebulizer treatments, DECADRON, BENADRYL, and supplemental oxygen, and the patient was transported to the hospital. He responded well to treatment, and the event subsequently recovered.
Age: 3.0
Sex: M
Vaccine: DTAP, DTAP
Symptoms: Injected limb mobility decreased, Injection site swelling, Pain
Clinical narrative: DTaP given in Left thigh. Developed swollen Left knee (not red or warm) within hours after vaccination. Developed only a 5 mm red papule at site of injection. No fever.
Age: 3.0
Sex: M
Vaccine: DTAP, DTAP
Symptoms: Injection site papule, Injection site swelling
Clinical narrative: DTaP given in Left thigh. Developed swollen Left knee (not red or warm) within hours after vaccination. Developed only a 5 mm red papule at site of injection. No fever.
Sex: U
Vaccine: MMR
Symptoms: Death
Clinical narrative: Information has been received from a consumer concerning a young baby who on an unknown date was vaccinated with a dose of MMR II. Subsequently, the baby died locally. No further information is available.
Age: 3.0
Sex: U
Vaccine: HIBV
Symptoms: Haemophilus bacteraemia, Intensive care, Meningitis haemophilus
Clinical narrative: A 3-year-old child had received their two and four month Hib immunizations (manufacturer, lot number and dates of administration not reported) and subsequently developed Hib bacteremia and meningitis in late February 2009. The child was reported to have been under-vaccinated and had not completed the Hib vaccine series with the six month and 12-15 month vaccine doses. At the time of the report, the child was hospitalized in intensive care and recovering. No further information was provided. Documents held by sender: None.
Age: 1.7
Sex: M
Vaccine: DTAP, HEPA, MMR
Symptoms: Blood culture negative, Body temperature increased, Dyskinesia, Electroencephalogram normal, Fall
Clinical narrative: Initial report received on 13 March 2009 from a health care professional. A 20-month-old male patient had received on 04 March 2009 a fourth intramuscular left thigh injection of DAPTACEL (lot number C3083BA); a second intramuscular right thigh injection of VAQTA (manufacturer Merck, lot number 1379V); and a first intramuscular right thigh injection of MMR II (manufacturer Merck, lot number 13654). The patient has no family history of epilepsy, but the last week of February 2009 had experienced a fall where he hit his head on wooden furniture (no loss of consciousness) requiring emergency room visit and seven stitches in the head. On 05 March 2009, i.e., the following day after receiving the vaccinations, the patient was visiting the grandparents and in the afternoon he woke up from a nap lethargic, staring and moving his head around slowly with no facial "responses." This continued for a few hours. Later while trying to follow behind the grandmother the patient fell backwards on his head. At that time, the grandmother described the patient as looking like he had "hiccups over his whole body" and she summoned a neighbor for help who happened to be a physician. The physician "timed the activity for four minutes" and the patient was taken to the emergency room which was around 19:30 pm. The patient was afebrile and underwent diagnostic tests of a "spinal catheterization" and blood cultures that were negative. The following morning around 01:30 am, the patient had a temperature of 101.5 degrees Fahrenheit that lasted approximately one hour. A urine test revealed "few white blood cells" and the patient received a seven day course of BACTRIM. The patient was discharged from the emergency room 12 hours after arriving. On 13 March 2009, the patient was evaluated by his physician and at that time had no symptoms. Per the physician, the patient was active and "normal." An EEG was completed that was negative. The patient was then referred to a neurologist. The recovery status of the patient was reported as "unknown." Documents held by sender: None.
Age: 1.7
Sex: M
Vaccine: DTAP, HEPA, MMR
Symptoms: Head injury, Lethargy, Lumbar puncture, Staring, Unresponsive to stimuli
Clinical narrative: Initial report received on 13 March 2009 from a health care professional. A 20-month-old male patient had received on 04 March 2009 a fourth intramuscular left thigh injection of DAPTACEL (lot number C3083BA); a second intramuscular right thigh injection of VAQTA (manufacturer Merck, lot number 1379V); and a first intramuscular right thigh injection of MMR II (manufacturer Merck, lot number 13654). The patient has no family history of epilepsy, but the last week of February 2009 had experienced a fall where he hit his head on wooden furniture (no loss of consciousness) requiring emergency room visit and seven stitches in the head. On 05 March 2009, i.e., the following day after receiving the vaccinations, the patient was visiting the grandparents and in the afternoon he woke up from a nap lethargic, staring and moving his head around slowly with no facial "responses." This continued for a few hours. Later while trying to follow behind the grandmother the patient fell backwards on his head. At that time, the grandmother described the patient as looking like he had "hiccups over his whole body" and she summoned a neighbor for help who happened to be a physician. The physician "timed the activity for four minutes" and the patient was taken to the emergency room which was around 19:30 pm. The patient was afebrile and underwent diagnostic tests of a "spinal catheterization" and blood cultures that were negative. The following morning around 01:30 am, the patient had a temperature of 101.5 degrees Fahrenheit that lasted approximately one hour. A urine test revealed "few white blood cells" and the patient received a seven day course of BACTRIM. The patient was discharged from the emergency room 12 hours after arriving. On 13 March 2009, the patient was evaluated by his physician and at that time had no symptoms. Per the physician, the patient was active and "normal." An EEG was completed that was negative. The patient was then referred to a neurologist. The recovery status of the patient was reported as "unknown." Documents held by sender: None.
Age: 1.7
Sex: M
Vaccine: DTAP, HEPA, MMR
Symptoms: White blood cells urine positive
Clinical narrative: Initial report received on 13 March 2009 from a health care professional. A 20-month-old male patient had received on 04 March 2009 a fourth intramuscular left thigh injection of DAPTACEL (lot number C3083BA); a second intramuscular right thigh injection of VAQTA (manufacturer Merck, lot number 1379V); and a first intramuscular right thigh injection of MMR II (manufacturer Merck, lot number 13654). The patient has no family history of epilepsy, but the last week of February 2009 had experienced a fall where he hit his head on wooden furniture (no loss of consciousness) requiring emergency room visit and seven stitches in the head. On 05 March 2009, i.e., the following day after receiving the vaccinations, the patient was visiting the grandparents and in the afternoon he woke up from a nap lethargic, staring and moving his head around slowly with no facial "responses." This continued for a few hours. Later while trying to follow behind the grandmother the patient fell backwards on his head. At that time, the grandmother described the patient as looking like he had "hiccups over his whole body" and she summoned a neighbor for help who happened to be a physician. The physician "timed the activity for four minutes" and the patient was taken to the emergency room which was around 19:30 pm. The patient was afebrile and underwent diagnostic tests of a "spinal catheterization" and blood cultures that were negative. The following morning around 01:30 am, the patient had a temperature of 101.5 degrees Fahrenheit that lasted approximately one hour. A urine test revealed "few white blood cells" and the patient received a seven day course of BACTRIM. The patient was discharged from the emergency room 12 hours after arriving. On 13 March 2009, the patient was evaluated by his physician and at that time had no symptoms. Per the physician, the patient was active and "normal." An EEG was completed that was negative. The patient was then referred to a neurologist. The recovery status of the patient was reported as "unknown." Documents held by sender: None.
Age: 1.4
Sex: M
Vaccine: RUB
Symptoms: Autism spectrum disorder, Blood test, Immune system disorder, Mental disorder due to a general medical condition, Mobility decreased
Clinical narrative: Information has been received from a consumer concerning her son with no medical history or allergies who on 20-SEP-2006 was vaccinated with a dose of MERUVAX II. Subsequently the patient started to have problems where he was not being able to bring his hand up to his face, was shaking, and had developed immune system problems sometime after receiving MERUVAX II. The patient had been diagnosed at one point with pervasive development disorder (PDD) and organic brain syndrome. He was also noted to be in the autism spectrum. Lab diagnostic studies performed included blood work. He was improving at the time of reporting. The consumer also mentioned prior to receiving MERUVAX II, the patient received a dose of MUMPSVAX on 16-MAY-2006 and VARIVAX (Merck) on 07-JUN-2006, but no adverse event was noted after those two vaccines. The patient sought unspecified medical attention. Upon internal review, pervasive development disorder (PDD) was determined to be an other important medical event. No further information is available.
Age: 1.4
Sex: M
Vaccine: RUB
Symptoms: Tremor
Clinical narrative: Information has been received from a consumer concerning her son with no medical history or allergies who on 20-SEP-2006 was vaccinated with a dose of MERUVAX II. Subsequently the patient started to have problems where he was not being able to bring his hand up to his face, was shaking, and had developed immune system problems sometime after receiving MERUVAX II. The patient had been diagnosed at one point with pervasive development disorder (PDD) and organic brain syndrome. He was also noted to be in the autism spectrum. Lab diagnostic studies performed included blood work. He was improving at the time of reporting. The consumer also mentioned prior to receiving MERUVAX II, the patient received a dose of MUMPSVAX on 16-MAY-2006 and VARIVAX (Merck) on 07-JUN-2006, but no adverse event was noted after those two vaccines. The patient sought unspecified medical attention. Upon internal review, pervasive development disorder (PDD) was determined to be an other important medical event. No further information is available.
Age: 54.0
Sex: M
Vaccine: PPV
Symptoms: Burning sensation, Cellulitis, Chills, Cough, Echocardiogram normal
Clinical narrative: Information has been received from a pharmacist concerning a 54 year old male with hypertension, obesity, diabetes, atherosclerosis, asthma and heart murmur who on 03-MAR-2009 was vaccinated with PNEUMOVAX (Lot# 662018/1332X) in the left arm for prophylaxis against high risk pneumonia. The patient had no known drug reactions/allergies. Concomitant therapy included TYLENOL, METOPROLOL XL, LISINOPRIL (manufacturer unknown), VYTORIN, ASPIRIN, PROAIR HFA, IBUPROFEN, ZYRTEC, FLUTICASONE, INDOMETHACIN (manufacturer unknown) and ALBUTEROL. On 04-MAR-2009 evening, the patient experienced fever, chills and increasing pain in the deltoid region where the shot was given (left arm). The patient experienced swollen arm, red hot to touch of the left arm, chronic cough, "burning lung with body aches that were hot and cold" and redness at the injection site. The patient was in the office on 05-MAR-2009 and the patient had pain down the left arm where erythematous area of the skin where the vaccination was given. The patient had a dry cough without shortness of breath. The patient vomited shortly after examination. The patient was sent to the hospital on 5-MAR-2009 with a diagnosis of cellulitis. The patient was hospitalized. The patient was discharged with homecare with a PIC line and ROCEPHIN IV daily for 7 days and BACTRIM DS twice daily for 7 days to prevent the spread of infection. The patient was to follow up with infectious disease. The patient was discharged in satisfactory condition on 10-MAR-2009. The adverse events were considered to be significant disability or incapacity. Fever, chills, swollen arm, red hot to touch of the left arm, chronic cough, "burning lung with body aches that were hot and cold" and redness at the injection site, increasing pain in the deltoid region where the shot was given (left arm) pain down the left arm where erythematous area of the skin where the vaccination as given, dry cough without shortness of breath, vomited, and cellulitis were determined to be other important medical events. Additional information has been requested.
Age: 54.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Feeling of body temperature change, Injection site erythema, Injection site pain, Nuclear magnetic resonance imaging abnormal
Clinical narrative: Information has been received from a pharmacist concerning a 54 year old male with hypertension, obesity, diabetes, atherosclerosis, asthma and heart murmur who on 03-MAR-2009 was vaccinated with PNEUMOVAX (Lot# 662018/1332X) in the left arm for prophylaxis against high risk pneumonia. The patient had no known drug reactions/allergies. Concomitant therapy included TYLENOL, METOPROLOL XL, LISINOPRIL (manufacturer unknown), VYTORIN, ASPIRIN, PROAIR HFA, IBUPROFEN, ZYRTEC, FLUTICASONE, INDOMETHACIN (manufacturer unknown) and ALBUTEROL. On 04-MAR-2009 evening, the patient experienced fever, chills and increasing pain in the deltoid region where the shot was given (left arm). The patient experienced swollen arm, red hot to touch of the left arm, chronic cough, "burning lung with body aches that were hot and cold" and redness at the injection site. The patient was in the office on 05-MAR-2009 and the patient had pain down the left arm where erythematous area of the skin where the vaccination was given. The patient had a dry cough without shortness of breath. The patient vomited shortly after examination. The patient was sent to the hospital on 5-MAR-2009 with a diagnosis of cellulitis. The patient was hospitalized. The patient was discharged with homecare with a PIC line and ROCEPHIN IV daily for 7 days and BACTRIM DS twice daily for 7 days to prevent the spread of infection. The patient was to follow up with infectious disease. The patient was discharged in satisfactory condition on 10-MAR-2009. The adverse events were considered to be significant disability or incapacity. Fever, chills, swollen arm, red hot to touch of the left arm, chronic cough, "burning lung with body aches that were hot and cold" and redness at the injection site, increasing pain in the deltoid region where the shot was given (left arm) pain down the left arm where erythematous area of the skin where the vaccination as given, dry cough without shortness of breath, vomited, and cellulitis were determined to be other important medical events. Additional information has been requested.
Age: 54.0
Sex: M
Vaccine: PPV
Symptoms: Oedema peripheral, Pain, Pyrexia, Skin warm, Vomiting
Clinical narrative: Information has been received from a pharmacist concerning a 54 year old male with hypertension, obesity, diabetes, atherosclerosis, asthma and heart murmur who on 03-MAR-2009 was vaccinated with PNEUMOVAX (Lot# 662018/1332X) in the left arm for prophylaxis against high risk pneumonia. The patient had no known drug reactions/allergies. Concomitant therapy included TYLENOL, METOPROLOL XL, LISINOPRIL (manufacturer unknown), VYTORIN, ASPIRIN, PROAIR HFA, IBUPROFEN, ZYRTEC, FLUTICASONE, INDOMETHACIN (manufacturer unknown) and ALBUTEROL. On 04-MAR-2009 evening, the patient experienced fever, chills and increasing pain in the deltoid region where the shot was given (left arm). The patient experienced swollen arm, red hot to touch of the left arm, chronic cough, "burning lung with body aches that were hot and cold" and redness at the injection site. The patient was in the office on 05-MAR-2009 and the patient had pain down the left arm where erythematous area of the skin where the vaccination was given. The patient had a dry cough without shortness of breath. The patient vomited shortly after examination. The patient was sent to the hospital on 5-MAR-2009 with a diagnosis of cellulitis. The patient was hospitalized. The patient was discharged with homecare with a PIC line and ROCEPHIN IV daily for 7 days and BACTRIM DS twice daily for 7 days to prevent the spread of infection. The patient was to follow up with infectious disease. The patient was discharged in satisfactory condition on 10-MAR-2009. The adverse events were considered to be significant disability or incapacity. Fever, chills, swollen arm, red hot to touch of the left arm, chronic cough, "burning lung with body aches that were hot and cold" and redness at the injection site, increasing pain in the deltoid region where the shot was given (left arm) pain down the left arm where erythematous area of the skin where the vaccination as given, dry cough without shortness of breath, vomited, and cellulitis were determined to be other important medical events. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: MMR
Symptoms: Autism, Condition aggravated
Clinical narrative: Information has been received from a nurse practitioner concerning her approximately 30 month old grandson with a little autism prior to receiving the vaccination who on an unspecified date was vaccinated with a dose of MMR II. It was reported that the patient's autism accelerated. The outcome was unknown. It was not specified if the patient sought medical attention or not. Upon internal review, the autism accelerated was considered to be other important medical event. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Autism, Laboratory test abnormal
Clinical narrative: Information has been received from a consumer concerning her 5 year old son with no medical history or allergies who was vaccinated with a dose of MMR II (lot number not available) 3 years ago (in March 2006). Concomitant medications included unspecified antibiotics. Shortly after receiving MMR II he was diagnosed with autism. Lab diagnostics studies included autism tests. He did not recover at the time of reporting. The patient was seen by several physicians for medical attention. Upon internal review, autism was determined to be an other important medical event. No further information is available.
Age: 1.5
Sex: M
Vaccine: MMR
Symptoms: Autism
Clinical narrative: Information has been received from a consumer concerning her 18 month old nephew with no medical history who in January 2008, was vaccinated with a dose of MMR II 0.5 mL, subcutaneously. It was reported that the patient could have been on other medications. The reporter stated that at 18 months old, the patient was diagnosed with autism after getting vaccinated with MMR II. At the time of this report, the patient was recovering. The patient sought unspecified medical attention. Upon internal review, autism was considered an other important medical event. This is one of several reports from the same source. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Autism
Clinical narrative: Information has been received from a consumer who reported that she has 3 friends whose children were vaccinated with a dose of MMR II and developed autism. Upon internal review, autism was considered an other important medical event. This is one of several reports from the same source. Attempts to verify the existence of an identifiable patient have been unsuccessful. No further information is available.
Age: 15.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Drug exposure during pregnancy, Foetal disorder, Pregnancy test positive, Premature baby
Clinical narrative: Information has been received from a registered nurse, for the Pregnancy Registry for GARDASIL concerning a 15 year old female with attention deficit/hyperactivity disorder who denied she was pregnant on 06-MAY-2008 and was vaccinated IM with a first 0.5 mL dose of GARDASIL (lot # 659437/1266U).  Concomitant therapy on the same day included a dose of MENACTRA (Sanofi Pasteur).  Other medications included "STRAITERA", but has stopped taking this.  On 27-MAY-2008 the patient saw her family doctor and a pregnancy test confirmed the pregnancy.  On 09-JUN-2008, the patient was seen in the health department office stating she was pregnant and was enrolled in the WIC program.  The patient's LMP was reported to be 23-APR-2008.  Follow-up information was received from the registered nurse via a completed pregnancy questionnaire.  It was reported that the female patient had no concurrent medical conditions (also reported as unknown) and smoked 3 cigarettes per day when first pregnant.  The patient had no previous pregnancy.  On 09-JUN-2008 the patient stated that she was taking STRATTERA before pregnancy and did not take during pregnancy.  The medication used during this pregnancy was unknown.  The patient had some bleeding in early pregnancy.  On 08-OCT-2008 a baby girl was delivered prematurely at 26 weeks gestation in a hospital.  The baby weighed 1 pound and 11 ounces.  The length was 12 inches.  The head circumference was 21.5 inches.  The baby had congenital heart and breathing problems.  It was reported that the complication during labor/delivery, the diagnostic test during pregnancy and the infections or illnesses during pregnancy was unknown.  Upon internal review, born prematurely at 26 weeks and birth weight 1 pound and 11 ounces were considered to be other important medical events.  Additional information is not expected.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Drug exposure during pregnancy, Ultrasound scan normal
Clinical narrative: Initial information has been received through the Merck Pregnancy Registry for GARDASIL from a registered nurse concerning a 20 year old female with a penicillin allergy and attention deficit/hypersensitivity disorder who on 03-JUN-2008 was vaccinated with the first dose of GARDASIL (LOT# 660387/1967U). There was no concomitant therapy. Subsequently, she became pregnant. On 06-AUG-2008, an ultrasound was performed with the result "looks okay". The date of her last menstrual period was 01-MAY-2008 and the estimated delivery date is 14-FEB-2009. The patient's outcome was unknown. The patient called the physician's office. Follow-up information has been received from a registered nurse to report the pregnancy outcome. On 15-JAN-2009 the patient delivered a normal, healthy male baby weighing 6 pounds 13 ounces. The baby's length was 19.5 inches and head circumference was 13.5 inches with unsure apgar score. There were no congenital anomalies. The baby wouldn't suck. He was placed in neonatal intensive care unit (NICU) and received tube feeding for 8 days. During pregnancy, there was no complication, infection and illness for the patient. The patient took prenatal vitamins daily. There was also no complication during labor/delivery. Additional information is not expected.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Cough, Dyspnoea, Glossodynia, Oral pain, Periorbital oedema
Clinical narrative: Within 10 min. of vaccines pt. had cough, sneezing. Tongue and mouth pain. Doctor found periorbital edema with wheals, no swelling of lip or tongue no wheezing. 25 mg BENADRYL given; then pt. had dyspnea with cough and stridor. .5mg Epinephrine sq. EMS transport to ER. 3/20/09-records received for DOS 3/17-3/18/09-DC DX: anaphylaxis following vaccines. Shortly after receiving vaccines developed anaphylactic reaction with hives and difficulty breathing. Angioedema. Obsrved overnight.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Sneezing, Stridor, Urticaria
Clinical narrative: Within 10 min. of vaccines pt. had cough, sneezing. Tongue and mouth pain. Doctor found periorbital edema with wheals, no swelling of lip or tongue no wheezing. 25 mg BENADRYL given; then pt. had dyspnea with cough and stridor. .5mg Epinephrine sq. EMS transport to ER. 3/20/09-records received for DOS 3/17-3/18/09-DC DX: anaphylaxis following vaccines. Shortly after receiving vaccines developed anaphylactic reaction with hives and difficulty breathing. Angioedema. Obsrved overnight.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Injection site erythema
Clinical narrative: On 3/13/09 pt. received 3rd dose of PENTACEL, HEP B, PREVNAR & ROTATEQ.  Within 4 hours pt. developed large area of confluent erythema (see picture).  Pt. treated with BENEDRYL, 1/2 tsp. qid.  Seen on 3/14/09. <- erythema had greatly improved.  No wheeze, and pt. appeared to act normally.
Age: 35.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Approx.  24-28 after 12 pt. noted swelling redness & heat @ inj. site on left upper arm 4 cm X 2 cm area.  Instructed to use compresses & TYLENOL.  Should resolve in a week.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Influenza, Influenza serology positive
Clinical narrative: Pt received flu vaccine & got INFLUENZA B anyway.
Age: 18.0
Sex: F
Vaccine: HPV4, MEN, TDAP
Symptoms: Agitation, Blood test abnormal, Dyspnoea, Hypoaesthesia, Malaise
Clinical narrative: Feb-2-09 at 3:00 pm vaccines were given  Within 5 minutes of vaccines, she was feeling nauseated and  a numbness in right arm which started to spread to whole body, then was feeling shortness of breath and feeling very agitated.  I took her back to the same nurse whom gave her the shots and she had my daughter lay down for about 15 minutes and while laying down my daughter started to have episode of feeling ill the nurse told her to lay down for 15 more minutes and then told her she was fine to go home.
Age: 18.0
Sex: F
Vaccine: HPV4, MEN, TDAP
Symptoms: Nausea, Pain in extremity
Clinical narrative: Feb-2-09 at 3:00 pm vaccines were given  Within 5 minutes of vaccines, she was feeling nauseated and  a numbness in right arm which started to spread to whole body, then was feeling shortness of breath and feeling very agitated.  I took her back to the same nurse whom gave her the shots and she had my daughter lay down for about 15 minutes and while laying down my daughter started to have episode of feeling ill the nurse told her to lay down for 15 more minutes and then told her she was fine to go home.
Age: 72.0
Sex: M
Vaccine: YF
Symptoms: Headache, Somnolence
Clinical narrative: Increased somnolence and headache.
Age: 1.1
Sex: M
Vaccine: HIBV, MMR, VARCEL
Symptoms: Rash maculo-papular
Clinical narrative: Diffuse macular papular rash.
Age: 81.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Cardiac stress test, Dizziness, Echocardiogram, Feeling hot
Clinical narrative: Pt went to a fast food restaurant after leaving our office.  Halfway there she got a pain in mid-sternal to epigastric region.  Then she felt very flushed, woozy, and hot.  She got out of the car & went into the restaurant still feeling a little woozy.  While ordering, she fainted & passed out.  911 was called.
Age: 81.0
Sex: F
Vaccine: VARZOS
Symptoms: Flushing, Laboratory test, Loss of consciousness, Syncope, Urine analysis
Clinical narrative: Pt went to a fast food restaurant after leaving our office.  Halfway there she got a pain in mid-sternal to epigastric region.  Then she felt very flushed, woozy, and hot.  She got out of the car & went into the restaurant still feeling a little woozy.  While ordering, she fainted & passed out.  911 was called.
Age: 0.13
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Crying
Clinical narrative: 3-4 hrs. of non-stop crying.
Age: 0.34
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Dyskinesia
Clinical narrative: Jerky movements of head to right
Age: 11.0
Sex: F
Vaccine: HEPA, MNQ, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Received Varicella and Hepatitis A vaccine in L arm on day prior to visit. This AM noted significant swelling erythema @ injection site. Area of erythema about 4cm diameter. Pt given hydrocortisone, BENADRYL.
Sex: F
Vaccine: HEP
Symptoms: No adverse event
Clinical narrative: Patient was given HEPATITIS B vaccine on 2/25 @ 17:30.  The second dose was given on 2/26 @ 02:00.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Erythema, Injection site erythema, Injection site swelling
Clinical narrative: Red swollen, painful (L) upper arm at area of injection.  Mild erythema & cellulitis.  PREDNISONE/CEPHALOXIN.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site urticaria, Urticaria
Clinical narrative: 48 hrs after the vaccine the site became red itchy swollen with scattered hives around the site & on trunk.
Age: 2.0
Sex: M
Vaccine: HEPA, PNC
Symptoms: Erythema, Injection site cellulitis, Pyrexia, Skin warm, Tenderness
Clinical narrative: Fever 102.7 48 hrs after administration cellulitis left anterior thigh.  3-4 cm annular area erythema and warmth.  Tenderness to touch.
Age: 1.4
Sex: M
Vaccine: DTAP, HIBV, PNC
Symptoms: Body temperature increased
Clinical narrative: Starting at 8:00PM on 3/18/09 Temp of 101 degrees.  3/19/09 Temp 102.9.  To use Tylenol or Motrin.  To take to ER if lethargic or not doing well.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Fatigue, Loss of consciousness, Nausea
Clinical narrative: Information has been received from a nurse practitioner concerning a 20 year old female with not drug reactions or allergies who on 20-FEB-2009 was vaccinated with a second dose of GARDASIL.  Concomitant therapy included hormonal contraceptives (unspecified).  On 21-FEB-2009 the patient experienced fatigue, nausea and dizziness.  On 23-FEB-2009 the patient passed out while taking a shower.  Subsequently, the patient recovered from these symptoms on 24-FEB-2009.  She sought unspecified medical attention.  Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Papilloma viral infection, Smear cervix abnormal
Clinical narrative: Information has been received from an aunt concerning her 15 year old niece with asthma who in July 2008, completed her three doses GARDASIL.  Subsequently this week on approximately 23-FEB-2009, the patient experienced PAP smear positive for HPV.  Lot numbers are not available.  The patient sought unspecified Medical attention.  No further information provided.  Additional information is not available.
Age: 38.0
Sex: F
Vaccine: DTAP
Symptoms: Arthralgia, Chills, Dizziness, Headache, Musculoskeletal pain
Clinical narrative: Began having chills, achy joints, shoulder (left) and neck pain (left arm received vaccine) around 2200 on eve of vaccine.  Began running fever of 100.2 by 0200 on 3/17.  Joint pain became worse by 1am with waves of severe pain in joints in knee, shoulder and neck.  By 5am of 3/17/09 having pressure in base of skull/neck causing headache, dizziness and nausea.  This much worse when standing, pressure still there when lying down.  This continued through this day.  Next day 3/18/09 still having pressure in neck/base of skull with headache and low grade temp (99.4). Joints still achy, but only rare episode of more intense joint pain.  This continues today on 3/19/09.
Age: 38.0
Sex: F
Vaccine: DTAP
Symptoms: Nausea, Neck pain, Pyrexia
Clinical narrative: Began having chills, achy joints, shoulder (left) and neck pain (left arm received vaccine) around 2200 on eve of vaccine.  Began running fever of 100.2 by 0200 on 3/17.  Joint pain became worse by 1am with waves of severe pain in joints in knee, shoulder and neck.  By 5am of 3/17/09 having pressure in base of skull/neck causing headache, dizziness and nausea.  This much worse when standing, pressure still there when lying down.  This continued through this day.  Next day 3/18/09 still having pressure in neck/base of skull with headache and low grade temp (99.4). Joints still achy, but only rare episode of more intense joint pain.  This continues today on 3/19/09.
Age: 35.0
Sex: F
Vaccine: TDAP
Symptoms: Body temperature increased, Pain, Pyrexia
Clinical narrative: DEVELOPED ACHING/ FEVER ABOUT 24 HOURS AFTER ADMINISTRATION OF TDAP.  TEMP 102 DEGREES, 48 HOURS LATER.  BODAY ACHES LASTED ABOUT 3 DAYS.
Age: 0.5
Sex: F
Vaccine: RV5
Symptoms: Culture stool negative, Gastroenteritis rotavirus, Rotavirus test positive, White blood cells stool negative
Clinical narrative: BREAKTHROUGH ROTAVIRUS DISPITE 3 DOSES OF ROTATEQ AT 2, 4, & 6 MTHS OF AGE
Age: 14.0
Sex: M
Vaccine: HEP, MNQ, TDAP, VARCEL
Symptoms: Body temperature increased, Crying, Hypokinesia, Pain
Clinical narrative: Has temp of 102, hurts to move, body achy all over, crying from pain, has not called MD, called at 10:30 this am.  Encouraged to call MD.
Age: 64.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Swelling
Clinical narrative: A red swelling developed that has been increasing in size with time. It has not resolved as yet. My wife is now taking zyrtec, pepcid and Keflin 500 mg 4 times a day  Shingles vaccine
Age: 0.33
Sex: F
Vaccine: DTAP, HIBV, IPV, TDAP
Symptoms: Wrong drug administered
Clinical narrative: Tdap given to patient in error, should have gotten HepB
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Blood culture negative, Chest X-ray normal, Drug exposure during pregnancy, Echocardiogram normal, Electrocardiogram normal
Clinical narrative: Flu vaccine administered at 10 a.m. when I was 34 weeks and 5 days pregnant. This was a twin pregnancy with lots of monitoring (ultrasounds, etc.) At approximately 3 p.m., my OB observed normal fetal heart activity in both babies. At 5:30 p.m. during a nonstress test, it was discovered that baby A had developed atrial flutter, with a heart rate of 422. Babies were surgically delivered the next morning due to this condition. Baby A was successfully cardioverted into a normal rhythm. Baby A was kept in NICU for three days to monitor cardiac status. 4/17/09-records received for DOS 10/13-10/17/08-admitted with 35 week twin pregnancy with fetal arrhythmia. Scheduled repeat cesarean delivery.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Foetal disorder
Clinical narrative: Flu vaccine administered at 10 a.m. when I was 34 weeks and 5 days pregnant. This was a twin pregnancy with lots of monitoring (ultrasounds, etc.) At approximately 3 p.m., my OB observed normal fetal heart activity in both babies. At 5:30 p.m. during a nonstress test, it was discovered that baby A had developed atrial flutter, with a heart rate of 422. Babies were surgically delivered the next morning due to this condition. Baby A was successfully cardioverted into a normal rhythm. Baby A was kept in NICU for three days to monitor cardiac status. 4/17/09-records received for DOS 10/13-10/17/08-admitted with 35 week twin pregnancy with fetal arrhythmia. Scheduled repeat cesarean delivery.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Urticaria
Clinical narrative: PATIENT NOTED HIVES ONCE AGAIN, ONLY THIS TIME WORSE, MOTHER GAVE PATIENT BENEDRYL AND PUT SOME CREAM ON HIVES TO RELIEVE THEM.  REACTION UNREPORTED THE FIRST TIME THAT IT OCCURED ON THE CHILD. HIVES APPEARED WITHIN 15 MINS THE SECOND TIME THAT CHILD HAD SHOT
Sex: M
Vaccine: DTAP
Symptoms: Pertussis, Pertussis identification test positive, Vaccination failure
Clinical narrative: Pt was fully immunized and pretty much on schedule but was still diagnosed with pertussis per PCR on 3/13/2009. Immunizations dates were 11/16/2005, 01/25/2006, 06/28/2006, 02/22/2007
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Urticaria
Clinical narrative: Infant developed hives 22 hours post immumizations on neck, trunk, and legs.  No swelling of lips nor difficulty breathing.  Consult to allergy clinic
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Pruritus, Rash
Clinical narrative: Within a few hours after receiving 4 vaccines, patient developed a rash over both upper arms that spread to lower arms, back, and face. He had no respiratory symptoms. He received benadryl for symptomatic relief of itching.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site haematoma
Clinical narrative: Saw a black dot on patient's left arm after administration of Varivax #2 using VanishPoint 5/8" syringe.
Age: 1.0
Sex: M
Vaccine: HEPA, PNC
Symptoms: Body temperature increased, Grand mal convulsion
Clinical narrative: Patient had 5 minute tonic clonic seizure with temp 101 on evening shots were given.  Patient had a history of prior febrile seizures.  Seen at Hospital and also had an otitis media which was diagnosed at the time of the immunizations.
Age: 5.0
Sex: F
Vaccine: FLU3, MMR
Symptoms: Injection site haematoma
Clinical narrative: Noticed black dot on patient's right arm immediately after administration of MMR. 04/16/2009 Office protocol requires MMR to be administered via Safety Glide needle.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Alanine aminotransferase increased, Anion gap, Aspartate aminotransferase increased, Basophil count decreased, Blood albumin normal
Clinical narrative: Patient complained of tightness and pain in his chest, went to the clinic at the Hospital on 15 Mar 09.  The clinic then transferred him to another hospital in where he was kept under observation for two days.  We have not yet received the paperwork from hospital as they have not processed the release of information request yet so we do not know the diagnosis from there. 3/24/09 Received hospital medical records of 3/16-3/17//2009. FINAL DX: myopericarditis Records reveal patient experienced intermittent chest pain x approx 2 days & 1 day which increased, tenderness at injection sites, left axillary pain.  Seen in outlying ER where EKG & cardiac enzymes were abnormal & transferred to higher level of care. Cardio consult done.  Tx w/ASA.  Remained stable, pain decreased & d/c to home w/Cardio f/u.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Blood alkaline phosphatase increased, Blood calcium normal, Blood chloride normal, Blood creatine phosphokinase increased, Blood creatinine increased
Clinical narrative: Patient complained of tightness and pain in his chest, went to the clinic at the Hospital on 15 Mar 09.  The clinic then transferred him to another hospital in where he was kept under observation for two days.  We have not yet received the paperwork from hospital as they have not processed the release of information request yet so we do not know the diagnosis from there. 3/24/09 Received hospital medical records of 3/16-3/17//2009. FINAL DX: myopericarditis Records reveal patient experienced intermittent chest pain x approx 2 days & 1 day which increased, tenderness at injection sites, left axillary pain.  Seen in outlying ER where EKG & cardiac enzymes were abnormal & transferred to higher level of care. Cardio consult done.  Tx w/ASA.  Remained stable, pain decreased & d/c to home w/Cardio f/u.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Blood glucose normal, Blood osmolarity decreased, Blood potassium decreased, Blood sodium normal, Blood urea normal
Clinical narrative: Patient complained of tightness and pain in his chest, went to the clinic at the Hospital on 15 Mar 09.  The clinic then transferred him to another hospital in where he was kept under observation for two days.  We have not yet received the paperwork from hospital as they have not processed the release of information request yet so we do not know the diagnosis from there. 3/24/09 Received hospital medical records of 3/16-3/17//2009. FINAL DX: myopericarditis Records reveal patient experienced intermittent chest pain x approx 2 days & 1 day which increased, tenderness at injection sites, left axillary pain.  Seen in outlying ER where EKG & cardiac enzymes were abnormal & transferred to higher level of care. Cardio consult done.  Tx w/ASA.  Remained stable, pain decreased & d/c to home w/Cardio f/u.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Carbon dioxide increased, Chest discomfort, Chest pain, Eosinophil count increased, Haematocrit normal
Clinical narrative: Patient complained of tightness and pain in his chest, went to the clinic at the Hospital on 15 Mar 09.  The clinic then transferred him to another hospital in where he was kept under observation for two days.  We have not yet received the paperwork from hospital as they have not processed the release of information request yet so we do not know the diagnosis from there. 3/24/09 Received hospital medical records of 3/16-3/17//2009. FINAL DX: myopericarditis Records reveal patient experienced intermittent chest pain x approx 2 days & 1 day which increased, tenderness at injection sites, left axillary pain.  Seen in outlying ER where EKG & cardiac enzymes were abnormal & transferred to higher level of care. Cardio consult done.  Tx w/ASA.  Remained stable, pain decreased & d/c to home w/Cardio f/u.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Haemoglobin normal, Lymphocyte count normal, Mean cell haemoglobin concentration, Mean cell haemoglobin normal, Mean cell volume
Clinical narrative: Patient complained of tightness and pain in his chest, went to the clinic at the Hospital on 15 Mar 09.  The clinic then transferred him to another hospital in where he was kept under observation for two days.  We have not yet received the paperwork from hospital as they have not processed the release of information request yet so we do not know the diagnosis from there. 3/24/09 Received hospital medical records of 3/16-3/17//2009. FINAL DX: myopericarditis Records reveal patient experienced intermittent chest pain x approx 2 days & 1 day which increased, tenderness at injection sites, left axillary pain.  Seen in outlying ER where EKG & cardiac enzymes were abnormal & transferred to higher level of care. Cardio consult done.  Tx w/ASA.  Remained stable, pain decreased & d/c to home w/Cardio f/u.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Mean platelet volume normal, Monocyte count increased, Neutrophil count normal, Platelet count normal, Protein total normal
Clinical narrative: Patient complained of tightness and pain in his chest, went to the clinic at the Hospital on 15 Mar 09.  The clinic then transferred him to another hospital in where he was kept under observation for two days.  We have not yet received the paperwork from hospital as they have not processed the release of information request yet so we do not know the diagnosis from there. 3/24/09 Received hospital medical records of 3/16-3/17//2009. FINAL DX: myopericarditis Records reveal patient experienced intermittent chest pain x approx 2 days & 1 day which increased, tenderness at injection sites, left axillary pain.  Seen in outlying ER where EKG & cardiac enzymes were abnormal & transferred to higher level of care. Cardio consult done.  Tx w/ASA.  Remained stable, pain decreased & d/c to home w/Cardio f/u.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Red blood cell abnormality, Red cell distribution width, Troponin increased, White blood cell count increased
Clinical narrative: Patient complained of tightness and pain in his chest, went to the clinic at the Hospital on 15 Mar 09.  The clinic then transferred him to another hospital in where he was kept under observation for two days.  We have not yet received the paperwork from hospital as they have not processed the release of information request yet so we do not know the diagnosis from there. 3/24/09 Received hospital medical records of 3/16-3/17//2009. FINAL DX: myopericarditis Records reveal patient experienced intermittent chest pain x approx 2 days & 1 day which increased, tenderness at injection sites, left axillary pain.  Seen in outlying ER where EKG & cardiac enzymes were abnormal & transferred to higher level of care. Cardio consult done.  Tx w/ASA.  Remained stable, pain decreased & d/c to home w/Cardio f/u.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Anion gap normal, Axillary pain, Blood calcium normal, Blood chloride normal, Blood creatine phosphokinase MB increased
Clinical narrative: Patient complained of tightness and pain in his chest, went to the clinic at the Hospital on 15 Mar 09.  The clinic then transferred him to another hospital in where he was kept under observation for two days.  We have not yet received the paperwork from hospital as they have not processed the release of information request yet so we do not know the diagnosis from there. 3/24/09 Received hospital medical records of 3/16-3/17//2009. FINAL DX: myopericarditis Records reveal patient experienced intermittent chest pain x approx 2 days & 1 day which increased, tenderness at injection sites, left axillary pain.  Seen in outlying ER where EKG & cardiac enzymes were abnormal & transferred to higher level of care. Cardio consult done.  Tx w/ASA.  Remained stable, pain decreased & d/c to home w/Cardio f/u.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Blood creatine phosphokinase increased, Blood creatinine increased, Blood glucose normal, Blood osmolarity decreased, Blood potassium normal
Clinical narrative: Patient complained of tightness and pain in his chest, went to the clinic at the Hospital on 15 Mar 09.  The clinic then transferred him to another hospital in where he was kept under observation for two days.  We have not yet received the paperwork from hospital as they have not processed the release of information request yet so we do not know the diagnosis from there. 3/24/09 Received hospital medical records of 3/16-3/17//2009. FINAL DX: myopericarditis Records reveal patient experienced intermittent chest pain x approx 2 days & 1 day which increased, tenderness at injection sites, left axillary pain.  Seen in outlying ER where EKG & cardiac enzymes were abnormal & transferred to higher level of care. Cardio consult done.  Tx w/ASA.  Remained stable, pain decreased & d/c to home w/Cardio f/u.